Search research articles
Contact Us
Filters
Showing results (381-390 of 453) with videos related to
Page
of 46
Sort By:
Neurology
|
February 8, 2023
Association of Employment Status With Symptom Burden and Health-Related Quality of Life in People Living With Primary CNS Tumors
Heather E Leeper, Elizabeth Vera, Alexa Christ, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2023
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Ying Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology Advances
|
September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency
Olga Kim, Madison Butler, Zach Sergi, et al.
Brain Pathology (Zurich, Switzerland)
|
March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system
Aditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Neuro-Oncology Advances
|
February 29, 2024
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings
Nicole Briceno, Elizabeth Vera, Edina Komlodi-Pasztor, et al.
Iscience
|
April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Ying Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology
|
May 15, 2016
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients
Amy K LeBlanc, Christina Mazcko, Diane E Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Neuro-Oncology Advances
|
October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Neuro-Oncology Practice
|
September 20, 2022
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments
Varna Jammula, James L Rogers, Elizabeth Vera, et al.
Page
of 46
Search research articles
Search
Showing results (381-390 of 453) with videos related to
Sort By:
Page
of 46
Neurology
|
February 8, 2023
Association of Employment Status With Symptom Burden and Health-Related Quality of Life in People Living With Primary CNS Tumors
Heather E Leeper, Elizabeth Vera, Alexa Christ, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2023
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Ying Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology Advances
|
September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency
Olga Kim, Madison Butler, Zach Sergi, et al.
Brain Pathology (Zurich, Switzerland)
|
March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system
Aditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Neuro-Oncology Advances
|
February 29, 2024
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings
Nicole Briceno, Elizabeth Vera, Edina Komlodi-Pasztor, et al.
Iscience
|
April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Ying Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology
|
May 15, 2016
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients
Amy K LeBlanc, Christina Mazcko, Diane E Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Neuro-Oncology Advances
|
October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Neuro-Oncology Practice
|
September 20, 2022
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments
Varna Jammula, James L Rogers, Elizabeth Vera, et al.
Page
of 46